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It has  been  demonstrated  clinically in  a  large number of human  subjects 
that  vaccination against  tularemia  is of value.  Foshay  (1)  has  administered 
vaccines which  demonstrably lowered  the  incidence  of disease  and  lessened 
the severity of the symptoms in exposed groups. The therapeutic use of immune 
serum in human infections was also shown by Foshay (2) to be advantageous. 
Experimentally, the value of either active or passive immunization has been 
difficult  to demonstrate.  Downs  (3)  and Larson  (4)  demonstrated some pro- 
tection of rabbits and of white rats, respectively, following active immunization. 
Francis and Felton (5) were unable to obtain any evidence of protective anti- 
body in sera from a  variety of experimentally immunized animals. Larson (6) 
showed evidence of protective antibody in sera from recovered and vaccinated 
human  beings.  Recently Foshay  et  al.  (7)  found  a  correlation  between  the 
protective titre  for rats  in sera  from immune goats and horses,  and the pre-  . 
cipitable antibody when a polysaccharide extracted from Pasteurella tularensis 
was used as the test antigen. The present study is concerned with the immune 
response  of  the  vaccinated  or  recovered  person  to  tularemia,  as  indicated 
by a  measurement  of antibody present  in  the  serum  which is  reactive with 
a  similar  polysaccharide antigen. 
Materials and Methods 
Sera.--Human sera included sixteen samples from individuals who had recovered from 
tularemia; eleven from individuals who had received Foshay's vaccine; two from individuals 
previously recovered from the disease who suffered reinfections; and three from individuals 
who had had no known contact with the organism. Unless otherwise stated, vaccinated per- 
sons were bled 2 weeks following the last injection of one or more series. 
The blood was allowed to clot at room temperature and was stored in the refrigerator 
overnight before removal of the serum. Unless otherwise specified, complement was removed 
by the addition of egg albumin containing 0.01 rag. N, and rabbit anti-egg albumin contain- 
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ing 0.1 rag. N, per ml. of serum, followed by incubation for 3 hours at 37°C. and 48 hours at 
0-4°C. The resulting precipitate was removed by centrffugation. 
Antigen.--The antigen used was a polysaccharide fraction of Past. tularensis,  strain Schu, 
which was isolated by the method of Palmer and Gerlough (8) in the manner described by 
Nicholes  (9).  Organisms were  grown in  Snyder's liquid  peptone medium  (10),  each flask 
being inoculated with one-fifth volume of an 18 hour culture and incubated on a mechanical 
shaker for 24 hours at  37°C.  The organisms were harvested by centrifugation at 0--4°C., 
washed twice with 0.85 per cent NaC1 solution, extracted at 37°C.  for 24 hours with acetone, 
dried in vacuo over CaC12, ground to a fine powder, and weighed. In two instances, 3.76 and 
8.69 gm. of dried organisms were obtained from 15 liters of medium. 
The organisms were extracted with liquefied crystalline phenol at 40°C. in a water bath. 
Five volumes of distilled water was added to the phenol-soluble fraction. The mixture was 
dialyzed in cellophane casing against running tap water, and then concentrated at 0-4°C. to 
approximately one-fourth volume by allowin~ a  fan to blow on it.  The concentrated fluid 
was centrifuged for 2 hours at 2,000 R.P.~.  in an International No. 2 centrifuge; the super- 
natant fluid was then centrifuged for 15 minutes at 5,000 R.P.~.  The final supernatant fluid 
was cooled to 0°C. and three volumes of cold 95 per cent ethyl alcohol was added while the 
flask was being shaken. The precipitate which formed was separated by centrifugation and 
redissolved in a  small quantity of distilled water.  Three reprecipitations were done, using 
alcohol which was made slightly alkaline to litmus with NaOH and which contained 0.2 per 
cent sodium acetate. The final precipitate was dissolved in distilled water and lyophilized. 
Concentrated solutions were made in 0.85 per cent NaC1 solution and stored at -30°C. 
Quantitative Precipitation.--The general technique of Heidelberger (11) was followed. Com- 
plement-free sera were added to a  series of  15 ml.  conical centrifuge tubes in duplicate or 
triplicate, in an amount dependent upon  the probable amount of antibody.  One or 2  ml. 
portions of sera were adequate when the serum was from a recovered person; a larger amount 
was necessary in sera from some vaccinated persons. In most cases the serum plus saline was 
added  in a  total quantity of 4  ml.  To each tube containing a  constant volume of diluted 
serum, 1 ml. of the variable concentrations of antigen was added; or in the case of controls, 
1 ml. of 0.85 per cent NaC1 solution. Concentrations of antigen were chosen to include three 
points in the antibody excess zone in which nearly 50 per cent of the total amount of antibody 
was expected to be precipitated. To insure sterility, aseptic technique was followed through- 
out, and merthiolate was added to a final concentration of 1-10,000. After thorough mixing, 
the tubes were incubated in a water bath at 37°C. for 3 hours, then at 0-4°C. for 10 to 14 
days, during which time they were shaken every other day. The tubes were centrifuged at 
0-4°C. and the precipitates washed three times with cold 0.85 per cent NaCI solution. The 
supernatant fluids were examined for the presence of excess antigen or antibody; the pre- 
cipitates were analyzed for nitrogen using the cnlorimetric technique of Heidelberger and 
MacPherson (12). 
The data were analyzed by the method of Heidelberger (11), including for each analysis 
only those points in the antibody excess zone in which 50 per cent or  more of the total anti- 
body was precipitated. The following values, all at the theoretical midpoint of the equivalence 
zone, were calculated for each serum: A,  the amount of antibody N  precipitated;  G,  the 
amount of antigen combined; and R, the ratio A/G. 
EXPERIMENTAL  RESETS 
The applicability of Heidelberger's equation to this antigen-antibody system, 
and  its  reliability  in  calculating  the  amount  of  nitrogen precipitable  by  any 
amount  of  antigen  in  the  antibody  excess  zone  are  shown by  the  results  re- TABLE I 
Comparison of Values of Precipitable Nitrogen Obtained in tke Antibody Excess Zone 
Experimentally and by Heiddberger's Equation 






















N  precipitated  (2  nil.  serum) 











Calculated 2 points 


















Faint trace A 
Faint trace A 
Calculated 9 points  Calculated 2 points, 0.10 and 0.15 
rag. N  ffi 0.541  G  -- 0.847  CJ  rag. N  -  0.545  G  -- 0.85  G  2 
R  ffi 0.271  R  ffi 0.273 
A  ffi 0.087  A  -- 0.087 
TABLE II 
Analyses of Normal Human Sera and of Sera from Human Beings Vaccinated with Past. 
~ularensis 
Serum No.  • 
VIII  5 
xxxiv  s§ 
II  4 
IV  4 
V  4 
VII  4 
XXXIII  4[I 
VI  3 
IX  3 
XXHI  3 
HI  2 
XII  None 
XIV  None 
XV 
No. series of 
vaccine$ 
None 



































































* All sera were obtained 2 weeks following the last injection of a  series unless otherwise 
specified. 
:~ Each series composed of three injections of 0.5 ml. each of Foshay's vaccine, except the 
first, which was one injection of 0.25 ml. followed by three injections of 0.5 ml. If on anyin- 
jection a  systemic or skin reaction appeared,  the  series was  considered  complete without 
further injections in that series. 
§ 3 years previously. 
[1 4 years previously. 
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corded in Table I. There is excellent agreement in the actual and theoretical 
values obtained,  even when  as  few  as  two  determinations in  the  antibody 
excess zone were used in calculating values. 
TABLE  III 
Analyses of Sera of Human Beings Recovered  from Tularemia 
SeruE  Serum No.*  used 
ml. 
XVII  1§ 
xvI  1§ 
XXI  2 
X  2 
X-a  2 
XXXI  2 
I  2 
XXIV  2 
XlX  I  § 
XXX  2 
Xl  2 
XI-a  2 
XXV  2 
XXII  2 
XXIX  2 
XXXII  2 
XX  2 




10 yrs., 6 mos. 
7 yrs. 
4 yrs., 1 too. 
2 wks. after  re- 
infection 
4 yrs. 
3 yrs., 9 mos. 
3 yrs., 8 mos. 
2 yrs., 8 mos. 
2 yrs. 
9 mos. 








Equivalence values (lOml. serum 
A  R  G 
Exposurel: afte, 
analysis 
rag.  N  rag. 
0.259  0.31'!  0.84  Exposed 
0.232  0.14  !  1.61 
0.228  0.28  0.82  Exposed 
0.622  0.54  1.16  Exposed 
0.537  0.47  i  1.14 
i 
0.475  0.42  1.14 
0.432  0.27  1.60  Exposed 
0.261  0.24  ]  1.10 
0.149  0.18  I  0.82 
0.235  0.21  1.14 
0.805  0.26  3.12  Exposed 
0.738  0.19  ]  3.84 
! 
0.581  0.42  1.38 
0.438  0.41  1.08 
0.895  0.48!  1.88 
2.385  0.44!  5.37 
0. 765  0.29  2.66  Exposed 
0.838  0.51  1.65 
* Four of these sera were obtained through the courtesy of Dr. C. M. Downs, University 
of Kansas, Department of Bacteriology~  Lawrence, Kansas; and three from Dr. Carl Larson, 
National Institutes of Health, Bethesda, Maryland. 
Individuals were considered exposed who were in contact with the organism to the ex- 
tent that caused infection in non-immune  persons. 
§ Stored 6 weeks at 0--4°C.  before testing; complement not absorbed. 
[[ Vaccinated and exposed for  2 years  previous  to  this  analysis;  postinfection  clinical 
diagnosis. 
¶ Vaccinated previously, and exposed for 6 months previous to this analysis; postinfection 
clinical diagnosis. 
The results presented in Table II show  that there is measurable, specific, 
antibody present in the sera after vaccination, but that the amount of antibody 
is not a function of the amount of vaccine administered. There is also apparent 
a  decrease of antibody when no further injections of antigen are made. 
The results presented in Table III show that there is a  tendency for more MARY  M.  ALEXANDER  55 
antibody to be present in the serum of individuals who have recovered from 
tularemia within the preceding year than in those who had the disease several 
years previously. 
Comparing  Tables  II  and  III  the  following  conclusions  may  be  drawn: 
the serum from a  recovered person contains more antibody than does serum 
from a vaccinated person; the ratio, A/G, is higher in serum from a  recovered 
person; in some instances, the amount of antigen which combines with a  unit 
volume of serum  is  about  the  same,  regardless  of the  previous immunizing 
experience of  the  person. 
A decrease in both the ratio and the amount of antibody following reinfection 
is exemplified by sera X-a and XI-a. In both there is a  significant decrease in 
A and R when compared to the previous analysis. Using serum XI-a, there was 
also an increase in the total amount of antigen (from 3.12 mg. N  to 3.83 mg. N) 
which  combined  with  the  antibody  which  the  serum  contained  following 
reinfection. 
DISCUSSION 
In the analyses in this study, a low A/G ratio was found in comparison with 
those  observed  in  comparable  studies  on  other  antigen-antibody  systems. 
Kabat  (13)  has  observed low  ratios  in  the  sera  of persons  immunized  with 
blood group A  substances,  a  fact which he attributes to the presence of non- 
reactive  material  in  the  antigen  preparation.  The  preparation  used  in  this 
study was antigenically homogeneous, as evidenced by its consistent behavior 
as  a  single antigen in precipitin tests  with animal and human  sera.  A  more 
precise method of preparation might yield a more active antigen; in fact, several 
preparations were compared seriologically using goat serum, and it was found 
that there was a  variation in their reactivity. There was also a  small amount 
of  insoluble  material  present  after lyophilization, and  the  reactivity of the 
solution remained unchanged after removal of this material by centrifugation 
in a  Sorvall high speed centrifuge. 
Amounts of precipitable antibody in sera from persons recovered from tula- 
remia varied from 0.149 to 2.3851 mg. N per 10 ml. serum; in sera from vaccin- 
ated persons, from 0.024 to 0.145 mg. N  per 10 ml. serum. These values are 
similar to those found by Heidelberger a  al,  (14-16)  in  the human response 
to the pneumococcus, which were 0.025 to 0.245 mg. N  per 10 ml. in the case 
of the previously infected person, and 0.025 to 0.145 mg. N  per 10 ml. in the 
case of the vaccinated person.  Kabat has  found N  values of 0.015  to 0.030 
mg.  N  per  10 ml.  serum in persons vaccinated with meningococcal polysac- 
charide (17); and values from 0.003 to 0.060 mg. N  per 10 ml. in persons vac- 
cinated with human blood group substance  (13). 
A  comparison of the amount of antibody and  the amount of antigen with 
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which it combined in sera  of vaccinated as contrasted to recovered persons, 
all of whom were subsequently exposed to an extent which provoked disease 
in normal persons, is of interest. Sera of the two vaccinated, exposed individuals 
(Nos.  II and XXHI, Table II) had no more  than one-half  the quantity of 
antibody which the four recovered, exposed persons had (Nos. I, XVII, XX, and 
XXI,  Table III); but the A/G ratio in the sera  of vaccinated persons  was 
only one-half as large  as that from recovered  persons,  and the antibody in 
these sera combined with an amount of antigen similar to that combined by 
sera  from recovered persons. 
In an analysis made 10 weeks after a clinical diagnosis of reinfection, (serum 
XI-a, Table III), the amount of antibody had decreased,  while the amount 
of antigen with which it combined had increased. Presumably the individual 
would  have a  higher level  of immunity because  of the stimulus of further 
antigen. 
If the  function of circulating  antibody in protecting an individual upon 
exposure  to disease is dependent on the ability of the antibody to assist in 
defending the body against the invasion of antigen, the value of that antibody 
in ~ivo could reasonably be a function not only of the quantity of antibody, 
but of its combining capacity as well. This hypothesis is substantiated in the 
disease tularemia by the work of Foshay et al.  (7) in which a close correlation 
was shown between  the protective capacity of immune goat and horse  sera 
for white rats, and the antibody as measured by the amount of polysaccharide 
neutralized. 
If this concept of immunity  in tularemia is tenable, the efficacy of vaccination 
against tularemia might better be determined by a method which measured 
the amount of antigen with which a given amount of antiserum would combine, 
rather  than the  amount of antibody alone. 
SUMMARY  AND  CONCLUSIONS 
A polysaccharide antigen,  prepared from a virulent  strain  of Past. t~arensis 
by phenol extraction,  was employed  in assaying the antibody in sera from 
persons  recovered  from  infection  with, or vaccinated with Past. tulare~sis, 
using the serological  technique of quantitative precipitation. 
Antibody levels in sera of individuals vaccinated with or recovered from 
infection  with Past. tularensis  were found to resemble those observed in similar 
studies by other investigators,  such as the antibody response to pneumococcal 
antigen, meningococcal polysaccharide, and blood group substances. 
It is suggested that the value of actively  or of passively acquired antibody 
to an individual exposed to tularemia is dependent not on the amount  of 
antibody alone, but also on the amount of antigen with which the antibody 
is capable of combining. 
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